Terrie Moffitt Seminar

TITLE: What if we could measure how fast we are aging, while we are still young and healthy? 
This lecture will answer questions like these:
How is a pace of aging measure valuable to the longevity industry?
How did our team follow 1000 people for 50 years to build a tool to measure aging?
What kinds of functions of the body and brain are tested to assess aging?  
What is an aging clock and how does it work?
How do we know the difference between fast aging and just being sick?
What is the difference between the longitudinal pace of aging and other aging clocks?
Will people who are aging faster die younger?
What aspects from early life lead to faster aging?
Will an aging clock slow down if we take medications or make lifestyle changes, what do Randomised Clinical Trials say?
Do aging clocks work in different ethnic groups?
What does a pace of aging score actually mean, and why is it significant?
What can an aging measure be used for in health care delivery?
Are there groups who are against extending longevity, and what are they thinking?

BIO: Terrie E. Moffitt, MBE, PhD, FBA
Professor of Social Development, King's College, London, and
Nannerl Keohane University Professor of Psychology, Duke University.
Professor Moffitt’s expertise is in the areas of mental health, biological aging, and longitudinal research methods. She is the associate director of the Dunedin Longitudinal Study, which follows a 1972 birth cohort in New Zealand. She also founded the Environmental Risk Longitudinal Twin Study (E-Risk), which follows a 1994 birth cohort in Britain. Moffitt is an elected fellow of the US National Academy of Medicine, Association of Psychological Science, American Society of Criminology, American Academy of Arts and Sciences, American Academy of Political & Social Sciences, the British Academy, and the UK Academy of Medical Sciences.  Her service includes major roles as member of the International Advisory Board of Bocconi University, chair of the Board on Behavioral, Cognitive and Sensory Sciences at the US National Academies of Sciences, chair of the National Institute on Aging’s Data-Monitoring Board for the Health and Retirement Study, and chair of the jury for the Klaus J. Jacobs Prize (Switzerland).Moffitt is recipient of the Member of the Most Excellent Order of the British Empire, the Stockholm Prize, the Swiss Klaus Jacobs Prize, the NARSAD Ruane Prize, and the 2022 Grawemeyer Prize for her work on mental health, and the Matilda White Riley Award from the NIH for her work on aging. She  holds honorary degrees from the University of Basel, University of Leuven, Universityof Cyprus, and Hebrew University Jerusalem. Moffitt received her PhD in psychology at the University of Southern California, and completed her postdoctoral training at the UCLA Neuropsychiatric Institute. She enjoys working on her poison-ivy farm in North Carolina. Learn more at www.moffittcaspi.com.